Showing 1 - 16 results of 16 for search 'N. Yu. Velts', query time: 0.02s Refine Results
  1. 1
    Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products

    Methodological Approaches to Risk Management of Advanced Therapy Medicinal Products by A. A. Taube, N. Yu. Velts

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier

    Expert Evaluation of Pharmacovigilance System Documents Included in the Registration Dossier by I. I. Snegireva, E. O. Zhuravleva, N. Yu. Velts

    Published 2020-12-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review)

    Denosumab and the Rebound Effect: Current Aspects of Osteoporosis Therapy (Review) by N. Yu. Velts, O. V. Velts, R. N. Alyautdin

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors

    Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors by N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Comparative Analysis of International Databases of Adverse Drug Reactions

    Comparative Analysis of International Databases of Adverse Drug Reactions by A. S. Kazakov, M. A. Darmostukova, T. M. Bukatina, N. Yu. Velts, R. N. Alyautdin

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Vaccine Safety International Monitoring

    Vaccine Safety International Monitoring by M. A. Darmostukova, I. I. Snegireva, N. Yu. Velts, A. S. Kazakov, R. N. Alyautdin

    Published 2019-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Drug-induced liver injuries in pregnancy in the context of polypragmasy

    Drug-induced liver injuries in pregnancy in the context of polypragmasy by N. Yu. Velts, E. O. Zhuravleva, M. A. Darmostukova, K. E. Zatolochina, O. S. Alyautdina

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Drug Safety Monitoring Information

    Drug Safety Monitoring Information by E. V. Shubnikova, E. O. Zhuravleva, N. Yu. Velts, P. M. Giulakhmedova, A. A. Druzhinina

    Published 2021-07-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE

    SIGNAL AS A TOOL OF THE PHARMACOVIGILANCE by E. O. Zhuravleva, N. Yu. Velts, G. V. Kutekhova, M. A. Darmostukova, R. N. Alyautdin

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    On improving the safety of new direct acting oral anticoagulants

    On improving the safety of new direct acting oral anticoagulants by N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, T. M. Bukatina, O. E. Zhuravleva, R. N. Alyautdin, B. K. Romanov

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Nanoscale Therapeutic System: Safety Assessment Features

    Nanoscale Therapeutic System: Safety Assessment Features by E. M. Bovina, B. K. Romanov, A. S. Kazakov, N. Yu. Velts, E. O. Zhuravleva, T. M. Bukatina, R. N. Alyautdin, V. A. Merkulov

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Ketoacidosis as unexpected adverse reaction SGLT<sub>2</sub> inhibitor

    Ketoacidosis as unexpected adverse reaction SGLT<sub>2</sub> inhibitor by T. M. Bukatina, A. S. Kazakov, N. Yu. Velts, M. A. Darmostukova, K. E. Zatolochina, R. N. Alyautdin, V. P. Dobrynin, B. K. Romanov

    Published 2018-02-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease

    Analysis of the Causes for Renal Dysfunction during Antibiotic Therapy in a Patient with Lyme Disease by N. Yu. Velts, E. O. Zhuravleva, G. V. Kutekhova, N. V. Tereshkina, A. O. Lovkova, K. V. Gorelov, V. A. Polivanov, S. M. Gyulakhmedova

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS

    ON THE ISSUE OF SAFETY OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS by N. Yu. Velts, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, M. A. Darmostukova, Yu. V. Olefir, B. K. Romanov, S. V. Glagolev, V. A. Polivanov

    Published 2018-09-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    International Drug Safety Monitoring

    International Drug Safety Monitoring by A. S. Kazakov, E. V. Shubnikova, M. A. Darmostukova, I. I. Snegireva, G. V. Kutekhova, K. E. Zatolochina, N. Yu. Velts, D. A. Kaperko, Yu. V. Olefir

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4

    UNEXPECTED ADVERSE REACTIONS OF THE DRUGS OF THE GROUP OF INHIBITORS OF DIPEPTIDYL PEPTIDASE-4 by T. V. Romanova, T. M. Bukatina, E. O. Zhuravleva, G. V. Kutekhova, I. I. Snegireva, M. A. Darmostukova, D. A. Kaperko, N. Yu. Velts, A. S. Kazakov, E. V. Shubnikova, R. N. Alyautdin

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: